Protein misfolding and prion diseases

Journal of Molecular Biology

Volumn 293, Issue 2, 1999, Pages 313-320

  Cohen, Fred E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Creutzfeldt Jakob disease; Prion; Protein folding

Indexed keywords

PRION PROTEIN;

ALZHEIMER DISEASE; HUMAN; INFECTION; INHERITANCE; KINETICS; MOLECULAR MODEL; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; REVIEW; THERMODYNAMICS;

EID: 0032742943     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2990     Document Type: Article

References (62)

1. Bellinger-Kawahara C. G., Kempner E., Groth D. F., Gabizon R., Prusiner S. B. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology. 164:1988;537-541.
2. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 379:1996;339-343.
3. Büeler H., Fischer M., Lang Y., Bluethmann H., Lipp H. P., DeArmond S. J., Prusiner S. B., Aguet M., Weissmann C. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
4. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1:1994;19-30.
5. Cohen F. E., Prusiner S. B. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67:1998;793-819.
6. Cohen F. E., Pan K. M., Huang Z., Baldwin M., Fletterick R. J., Prusiner S. B. Structural clues to prion replication. Science. 264:1994;530-531.
7. DeArmond S. J., Prusiner S. B. Transgenetics and neuropathology of prion diseases. Curr. Top. Microbiol. Immunol. 207:1996;125-146.
8. DeFea K. A., Nakahara D. H., Calayaga M. C., Yost C. S., Mirels L. F., Prusiner S. B., Vishwanath R. L. Determinants of carboxyl-terminal domain translocation during prion protein biogenesis. J. Biol. Chem. 269:1994;16810-16820.
9. Devillemeur T. B., Deslys J. P., Pradel A., Soubrie C., Alperovitch A., Tardieu M., Chaussain J. L., Jauw J. J., Dormont D., Ruberg M., Agid Y. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology. 47:1996;690-695.
10. Dlouhy S. R., Hsiao K., Farlow M. R., Foroud T., Conneally P. M., Johnson P., Prusiner S. B., Hodes M. E., Ghetti B. Linkage of the Indiana kindred of Gerstmann Sträussler-Scheinker disease to the prion protein gene. Nature Genet. 1:1992;64-67.
11. Donne D. G., Viles J. H., Groth D., Mehlhorn I., James T. L., Cohen F. E., Prusiner S. B., Wright P. E., Dyson H. J. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N-terminus is highly flexible. Proc. Natl Acad. Sci. USA. 94:1997;13452-13457.
12. Endo T., Groth D., Prusiner S. B., Kobata A. Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry. 28:1989;8380-8388.
13. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., Ott J., Prusiner S. B. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am. J. Hum. Genet. 53:1993;828-835.
14. Gasset M., Baldwin M. A., Lloyd D., Gabriel J. M., Holtzman D. M., Cohen F., Fletterick R., Prusiner S. B. Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl Acad. Sci. USA. 89:1992;10940-10944.
15. Goodfield J. Cannibalism and Kuru. Nature. 387:1997;841.
16. Hegde R. S., Mastrianni J. A., Scott M. R., DeFea K. A., Tremblay P., Torchia M., Dearmond S. J., Prusiner S. B., Lingappa V. R. A transmembrane form of the prion protein in neurodegenerative disease. Science. 279:1998;827-834.
17. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L. S., Lantos P. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450.
18. Hsiao K., Baker H. F., Crow T. J., Poulter M., Owen F., Terwilliger J. D., Westaway D., Ott J., Prusiner S. B. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature. 338:1989;342-345.
19. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 250:1990;1587-1590.
20. Hsiao K. K., Groth D., Scott M., Yang S. L., Serban H., Rapp D., Foster D., Torchia M., DeArmond S. J., Prusiner S. B. Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc. Natl Acad. Sci. USA. 91:1994;9126-9130.
21. Huang Z., Gabriel J. M., Baldwin M. A., Fletterick R. J., Prusiner S. B., Cohen F. E. Proposed three-dimensional structure for the cellular prior protein. Proc. Natl Acad. Sci. USA. 91:1994;7139-7143.
22. Huang Z., Prusiner S. B., Cohen F. E. Scrapie prions: a three-dimensional model of an infectious fragment. Fold. Design. 1:1996;13-19.
23. Jackson G. S., Hosszu L. L. P., Power A., Hill A. F., Kenney J., Saibil H., Craven C. J., Waltho J. P., Clarke A. R., Collinge J. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science. 283:1999;1935-1937.
24. James T. L., Liu H., Ulyanov N. B., Farr-Jones S., Zhang H., Donne D. G., Kaneko K., Groth D., Mehlhorn I., Prusiner S. B., Cohen F. E. Solution structure of a 142 residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc. Natl Acad. Sci. USA. 94:1997;10086-10091.
25. Jarrett J. T., Lansbury P. T. Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
26. Kaneko K., Wille H., Mehlhorn I., Zhang H., Ball H., Cohen F. E., Baldwin M. A., Prusiner S. B. Molecular properties of complexes formed between the prion protein and synthetic peptides. J. Mol. Biol. 270:1997a;574-586.
27. Kaneko K., Zulianello L., Scott M., Cooper C. M., Wallace A. C., James T. L., Cohen F. E., Prusiner S. B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl Acad. Sci. USA. 94:1997b;10069-10074.
28. Kelly J. W. The environmental dependency of protein folding best explains prion and amyloid diseases. Proc. Natl Acad. Sci. USA. 95:1998;930-932.
29. Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T. Jr, Caughey B. Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474.
30. Lashuel H. A., Lai Z., Kelly J. W. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30 M, and L55P amyloid fibril formation. Biochemistry. 37:1998;17851-17864.
31. Liemann S., Glockshuber R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry. 38:1999;3258-3267.
32. Lindquist S. Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell. 89:1997;495-498.
33. Matthews B. W. Structural and genetic analysis of the folding and function of T4 lysozyme. FASEB J. 10:1996;35-41.
34. McKinley M. P., Bolton D. C., Prusiner S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 35:1983;57-62.
35. Mehlhorn I., Groth D., Stockel J., Moffat B., Reilly D., Yansura D., Willett W. S., Baldwin M., Fetterick R., Cohen F. E., Vandlen R., Henner D., Prusiner S. B. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry. 35:1996;5528-5537.
36. Mirchev R., Ferrone F. A. The structural link between polymerization and sickle cell disease. J. Mol. Biol. 265:1997;475-479.
37. Montagna P., Cortelli P., Avoni P., Tinuper P., Plazzi G., Gallassi R., Portaluppi F., Julien J., Vital C., Delisle M. B., Gambetti P., Lugaresi E. Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol. 8:1998;515-520.
38. Pan K. M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA. 90:1993;10962-10966.
39. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S. G., Farlow M., Dickson D. W., Sima A. A., Trojanowski J. Q., Petersen R. B., Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:1996;767-778.
40. Peretz D., Williamson R. A., Matsunaga Y., Serban H., Pinilla C., Bastidas R. B., Rozenshteyn R., James T. L., Houghten R. A., Cohen F. E., Prusiner S. B., Burton D. R. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol. 273:1997;614-622.
41. Petersen R. B., Tabaton M., Berg L., Schrank B., Torack R. M., Leal S., Julien J., Vital C., Deleplanque B., Pendlebury W. W., Drachman D., Smith T. W., Martin J. J., Oda M., Montagna P. et al. Analysis of the prion protein gene in thalamic dementia. Neurology. 42:1992;245-251.
42. Poulter M., Baker H. L., Frith C. D., Leach M., Lofthouse R., Ridley R. M., Shah T., Owen F., Collinge J., Brown G., Hardy J., Muollan M. J., Harding A. E., Bennett C., Doshi R., Crow T. J. Inherited prion disease with 144 base pair gene insertion. Brain. 115:1992;675-685.
43. Prusiner S. B. Prion diseases and the BSE crisis. Science. 278:1997;245-251.
44. Prusiner S. B., Hsiao K. K. Human prion diseases. Ann. Neurol. 35:1994;385-395.
45. Prusiner S. B., Groth D. F., Bolton D. C., Kent S. B., Hood L. E. Purification and structural studies of a major scrapie prion protein. Cell. 38:1984;127-134.
46. Prusiner S. B., Groth D., Serban A., Koehler R., Foster D., Torchia M., Burton D., Yang S. L., DeArmond S. J. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl Acad. Sci. USA. 90:1993;10608-10612.
47. Prusiner S. B., Scott M. R., DeArmond S. J., Cohen F. E. Prion protein biology. Cell. 93:1998;337-348.
48. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wüthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature. 382:1996;180-182.
49. Sc molecules with different conformations. Nature Med. 4:1998;1157-1165.
50. Schifter S. Expression of the calcitonin gene family in medullary thyroid carcinoma. Peptides. 18:1997;307-317.
51. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S. J., Westaway D., Prusiner S. B. Transgenie mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell. 59:1989;847-857.
52. Scott M., Groth D., Foster D., Torchia M., Yang S. L., DeArmond S. J., Prusiner S. B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell. 73:1993;979-988.
53. Scott M., Safar J., Telling G., Nguyen O., Groth D., Torchia M., Koehler R., Tremblay P., Walther D., Cohen F. E., DeArmond S. J., Prusiner S. B. Identification of a prion protein epitope modulation transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc. Natl Acad. Sci. USA. 94:1997;14279-14284.
54. Stahl N., Baldwin M. A., Burlingame A. L., Prusiner S. B. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry. 29:1990;8879-8884.
55. Supattapone S., Bosque P., Muramoto T., Wille H., Aagard C., Peretz D., Nguyen H. O. B., Heinrich C., Torchia M., Safar J., Cohen F. E., DeArmond S. J., Prusiner S. B., Scott M. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell. 96:1999;869-878.
56. Telling G. C., Scott M., Hsiao K. K., Foster D., Yang S.-L., Torchia M., Sidle K. C. L., Collinge J., DeArmond S. J., Prusiner S. B. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc. Natl Acad. Sci. USA. 91:1994;9936-9940.
57. Telling G. C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F. E., DeArmond S. J., Prusiner S. B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 83:1995;79-90.
58. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagation prion diversity. Science. 274:1996;2079-2082.
59. Tremblay P., Meiner Z., Galou M., Heinrich C., Petromilli C., Lisse T., Cayetano J., Torchia M., Mobley W., Bujard H., DeArmond S. J., Prusiner S. B. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc. Natl Acad. Sci. USA. 95:1998;12580-12585.
60. Viles J. H., Cohen F. E., Prusiner S. B., Goodin D. B., Wright P. E., Dyson J. H. Copper binding to the prion protein: Structural implications of four identical cooperative binding sites. Proc. Natl Acad. Sci. USA. 96:1999;2042-2047.
61. Wickner R. B. Prions and RNA viruses of Saccharomyces cerevisiae. Annu. Rev. Genet. 30:1996;109-139.
62. Yost C. S., Lopez C. D., Prusiner S. B., Myers R. M., Lingappa V. R. Non-hydrophobic extracy to plasmic determinant of stop transfer in the prion protein. Nature. 343:1990;669-672.